Home
Portfolio
Béa Fertility
exit

Béa Fertility provides accessible and affordable at-home fertility treatment that has the same efficacy as a comparable in-clinic treatment at a friction of the price.

D2C subscription for at home fertility treatment

PROBLEM

One in six couples worldwide are struggling to conceive. The European Policy Audit on Fertility estimates that more than 25 million EU citizens are affected. In vitro fertilization treatments (“IVF”) are expensive, stressful and invasive. In addition there is not enough clinical capacity to meet the demand, thus most women who struggle to get pregnant are left alone.

SOLUTION

Bea Fertility has developed a simple tool enabling couples to perform Intracervical Insemination (ICI) at home. While ICI is a proven method that has been around for 50 years, clinics concentrate on the much more expensive Intrauterine Insemination (IUI). With the rebirth of ICI Bea enables women to take infertility into their own hands in the privacy of their homes.






Team members

Tess Cosad

Stage
Pre-Seed
Sector
Digital Health
Year invested
2021

More Use Cases

We are a fund built
by founders for founders

Successful founders supporting new founders in a way not yet seen in European venture capital. Let us be part of your journey!

Submit your pitch